ID26965A - Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid - Google Patents
Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroidInfo
- Publication number
- ID26965A ID26965A IDW20002095A ID20002095A ID26965A ID 26965 A ID26965 A ID 26965A ID W20002095 A IDW20002095 A ID W20002095A ID 20002095 A ID20002095 A ID 20002095A ID 26965 A ID26965 A ID 26965A
- Authority
- ID
- Indonesia
- Prior art keywords
- breast cancer
- aromatase
- medicine
- prevent
- treat breast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98104949A EP0943333A1 (de) | 1998-03-18 | 1998-03-18 | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
Publications (1)
Publication Number | Publication Date |
---|---|
ID26965A true ID26965A (id) | 2001-02-22 |
Family
ID=8231611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002095A ID26965A (id) | 1998-03-18 | 1999-03-03 | Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0943333A1 (cs) |
JP (1) | JP4920822B2 (cs) |
KR (1) | KR100778803B1 (cs) |
CN (1) | CN1168448C (cs) |
AT (1) | ATE230995T1 (cs) |
AU (1) | AU751040B2 (cs) |
BR (1) | BR9908885A (cs) |
CA (1) | CA2324077C (cs) |
CZ (1) | CZ292643B6 (cs) |
DE (1) | DE59904042D1 (cs) |
DK (1) | DK1063998T3 (cs) |
ES (1) | ES2190201T3 (cs) |
HU (1) | HU226105B1 (cs) |
ID (1) | ID26965A (cs) |
IL (1) | IL138292A (cs) |
PL (1) | PL343100A1 (cs) |
RU (1) | RU2225206C2 (cs) |
SK (1) | SK285349B6 (cs) |
WO (1) | WO1999047143A1 (cs) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042411A1 (de) * | 2000-08-30 | 2002-03-28 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Exemestan |
DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
JP4524296B2 (ja) * | 2007-03-30 | 2010-08-11 | 生化学工業株式会社 | 発毛促進剤 |
DE102007032468A1 (de) | 2007-07-10 | 2009-01-15 | Brätter, Christian, Dr. | Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten |
US11850451B2 (en) | 2011-01-31 | 2023-12-26 | Lucolas-M.D. Ltd. | Cosmetic compositions and methods for improving skin conditions |
ES2647566T3 (es) * | 2011-01-31 | 2017-12-22 | Lucolas-M.D. Ltd. | Combinaciones de inhibidores de aromatasa y antioxidantes |
JP2014516337A (ja) * | 2011-01-31 | 2014-07-10 | ルコラス エム・ディー リミテッド | 化粧用途 |
EP3666276A1 (en) * | 2018-12-14 | 2020-06-17 | dcic Biopharmaceutical Limited | Medication against estrogen-receptor beta (erbeta) positive breast tumor |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
DE3322285A1 (de) * | 1983-06-18 | 1984-12-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
JPS6345294A (ja) * | 1986-04-07 | 1988-02-26 | Shionogi & Co Ltd | アロマタ−ゼ阻害ステロイド誘導体 |
EP0310542B1 (de) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren |
FR2656310B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
DE4039559A1 (de) * | 1990-12-07 | 1992-06-11 | Schering Ag | Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln |
GB9212833D0 (en) * | 1992-06-17 | 1992-07-29 | Glaxo Group Ltd | Chemical compounds |
DK0689536T3 (da) * | 1993-03-16 | 2001-07-30 | Pfizer | Naphthalenderivater |
JPH07215992A (ja) * | 1993-12-07 | 1995-08-15 | Teikoku Hormone Mfg Co Ltd | 6−又は7−置換アンドロスタ−1,4−ジエン誘導体 |
EP0777458B1 (en) * | 1994-09-14 | 2000-12-06 | Central Sheffield University Hospitals NHS Trust | Control of hair growth |
US5780050A (en) * | 1995-07-20 | 1998-07-14 | Theratech, Inc. | Drug delivery compositions for improved stability of steroids |
AU1793397A (en) * | 1996-03-29 | 1997-10-22 | S.W. Patentverwertungs Ges. M.B.H. Edelsbacher U. Partner | Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite |
JP2000515523A (ja) * | 1996-07-22 | 2000-11-21 | ザ・ビクトリア・ユニバーシティ・オブ・マンチェスター | 創傷および線維性障害の治療における性ステロイド機能モジュレーターの使用 |
-
1998
- 1998-03-18 EP EP98104949A patent/EP0943333A1/de not_active Withdrawn
-
1999
- 1999-03-03 CN CNB998064009A patent/CN1168448C/zh not_active Expired - Lifetime
- 1999-03-03 ID IDW20002095A patent/ID26965A/id unknown
- 1999-03-03 IL IL13829299A patent/IL138292A/xx not_active IP Right Cessation
- 1999-03-03 HU HU0101005A patent/HU226105B1/hu not_active IP Right Cessation
- 1999-03-03 AT AT99913218T patent/ATE230995T1/de active
- 1999-03-03 ES ES99913218T patent/ES2190201T3/es not_active Expired - Lifetime
- 1999-03-03 PL PL99343100A patent/PL343100A1/xx unknown
- 1999-03-03 RU RU2000126276/15A patent/RU2225206C2/ru active IP Right Revival
- 1999-03-03 JP JP2000536383A patent/JP4920822B2/ja not_active Expired - Lifetime
- 1999-03-03 SK SK1342-2000A patent/SK285349B6/sk unknown
- 1999-03-03 DE DE59904042T patent/DE59904042D1/de not_active Expired - Lifetime
- 1999-03-03 AU AU31434/99A patent/AU751040B2/en not_active Expired
- 1999-03-03 WO PCT/EP1999/001374 patent/WO1999047143A1/de active IP Right Grant
- 1999-03-03 CA CA002324077A patent/CA2324077C/en not_active Expired - Fee Related
- 1999-03-03 BR BR9908885-1A patent/BR9908885A/pt not_active Application Discontinuation
- 1999-03-03 KR KR1020007010177A patent/KR100778803B1/ko not_active IP Right Cessation
- 1999-03-03 EP EP99913218A patent/EP1063998B1/de not_active Expired - Lifetime
- 1999-03-03 CZ CZ20003256A patent/CZ292643B6/cs not_active IP Right Cessation
- 1999-03-03 DK DK99913218T patent/DK1063998T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP1063998A1 (de) | 2001-01-03 |
DK1063998T3 (da) | 2003-05-12 |
CZ292643B6 (cs) | 2003-11-12 |
EP1063998B1 (de) | 2003-01-15 |
JP2002506823A (ja) | 2002-03-05 |
WO1999047143A1 (de) | 1999-09-23 |
HUP0101005A2 (hu) | 2001-08-28 |
AU751040B2 (en) | 2002-08-08 |
EP0943333A1 (de) | 1999-09-22 |
CA2324077C (en) | 2008-07-29 |
ES2190201T3 (es) | 2003-07-16 |
PL343100A1 (en) | 2001-07-30 |
HU226105B1 (en) | 2008-04-28 |
SK13422000A3 (sk) | 2001-05-10 |
IL138292A0 (en) | 2001-10-31 |
DE59904042D1 (de) | 2003-02-20 |
ATE230995T1 (de) | 2003-02-15 |
CN1301165A (zh) | 2001-06-27 |
KR100778803B1 (ko) | 2007-11-27 |
CZ20003256A3 (cs) | 2001-04-11 |
BR9908885A (pt) | 2000-11-21 |
KR20010034603A (ko) | 2001-04-25 |
CA2324077A1 (en) | 1999-09-23 |
RU2225206C2 (ru) | 2004-03-10 |
CN1168448C (zh) | 2004-09-29 |
JP4920822B2 (ja) | 2012-04-18 |
SK285349B6 (sk) | 2006-11-03 |
IL138292A (en) | 2005-08-31 |
AU3143499A (en) | 1999-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL365285A1 (en) | Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs | |
BR0315597A (pt) | Processos de baixa dose para tratamento de distúrbios em que a atividade de tnf(alfa)é prejudicial | |
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
BR9908592A (pt) | Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit | |
NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
BR9806060A (pt) | Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina. | |
BR0207316A (pt) | Derivados de epotilona para o tratamento de tumores refratários | |
MXPA04000654A (es) | Terapia dermica usando derivados de fosfato de agente de transferencia de electrones. | |
BR9509006A (pt) | Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele | |
MY164077A (en) | Compositions and uses of et743 for treating cancer | |
ID26965A (id) | Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid | |
SE9803761D0 (sv) | Method to avoid increased iridial pigmentation during prostaglandin treatment | |
HUP9801022A2 (hu) | Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására | |
GB0020504D0 (en) | Therapeutic method | |
HUP9901505A2 (hu) | Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására | |
AU2003250190A1 (en) | Combination of an aromatase inhibitor with a bisphosphonate | |
DE60030107D1 (de) | Vitamin-d derivate zur behandlung des systemischen lupus erythematodes | |
NZ511559A (en) | Use of staurosporine derivatives for treating ocular neovascular diseases | |
BR0115215A (pt) | Método para o tratamento de inflamações | |
ATE293972T1 (de) | Behandlung von chronischen schmerzen | |
PL367707A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
BR0111740A (pt) | Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação | |
RU94044457A (ru) | Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин | |
BR0315374A (pt) | Compostos orgânicos | |
AR015537A1 (es) | Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. |